HTG Molecular Diagnostics (HTGMQ) Stock Price, News & Analysis

Company Overview

HTG Molecular Diagnostics, Inc. was a molecular diagnostics and life sciences technology company headquartered in Tucson, Arizona. The company developed and commercialized RNA and gene-expression profiling technologies designed to analyze biological samples for research, drug development and diagnostic applications.

Its primary platform, EdgeSeq, used next-generation sequencing to measure gene expression and other molecular signals from tissue and liquid samples. HTG offered the EdgeSeq System, associated assay panels and laboratory services, including profiling services intended to support pharmaceutical research, biomarker discovery, translational research and clinical development.

HTG served biopharmaceutical companies, academic and research institutions, clinical laboratories and other organizations involved in precision medicine and molecular testing. The company was formerly known as High Throughput Genomics and adopted the HTG Molecular Diagnostics name as it expanded its focus on sequencing-based molecular profiling. HTG later entered financial difficulties and pursued a wind-down process; its former Nasdaq-listed securities subsequently traded under the HTGMQ symbol. Information about ongoing operations and current leadership is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 1,989 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/24/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Analytical instruments
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NASDAQ:HTGMQ
• CIK: 1169987
• Web: www.htgmolecular.com
• Phone: 877-289-2615
• Fax: 520-547-2837
• Employees: 90
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $6.37 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 630,000
• Free Float: 2,156,000
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 3.00